Cancer cell lines as patient avatars for drug response prediction

Patient-derived cancer cell lines could address two major challenges in oncology: real-time drug response prediction and the creation of massive knowledge banks. A new study showcases the power of this approach for precision oncology.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: A wealth of biological models for cancer research.


  1. 1.

    Hutter, C. & Zenklusen, J. C. Cell 173, 283–285 (2018).

  2. 2.

    Sanchez-Vega, F. et al. Cell 173, 321–337 (2018).

  3. 3.

    Iorio, F. et al. Cell 166, 740–754 (2016).

  4. 4.

    Lee, J.-K. et al. Nat. Genet. (2018).

  5. 5.

    van de Wetering, M. et al. Cell 161, 933–945 (2015).

  6. 6.

    Vlachogiannis, G. et al. Science 359, 920–926 (2018).

  7. 7.

    Lee, S. H. et al. Cell 173, 515–528 (2018).

Download references

Author information

Correspondence to Ultan McDermott.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading